Fungistatic Potential and Inhibition of Fungal Yeast-hyphae switch of Candida spp. by Hecogenin Acetate.

Hecogenin acetate inhibits fungal yeast-hyphae switch and exhibits fungistatic activity against Candida spp., with complete hyphal inhibition at high concentrations.

• Why it matters: Invasive fungal infections pose serious health risks, especially in immunocompromised patients, and current treatments face issues like toxicity and resistance, highlighting the need for new antifungal agents.
• What they did: The study tested hecogenin acetate's susceptibility against Candida strains using broth microdilution, examined its combination with fluconazole, and analyzed morphological changes in fungal forms through microculture.
• The result: Hecogenin acetate showed fungistatic effects, reduced fluconazole efficacy against C. krusei, and completely blocked yeast-to-hyphae transition at high doses, suggesting potential as a complementary antifungal therapy targeting virulence.